Vestmark Advisory Solutions, Inc. Viatris Inc Transaction History

Vestmark Advisory Solutions, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$9.02 - $10.29 $130,185 - $148,515	14,433 New	14,433 $144,000
Q1 2022 Apr 27, 2022	SELL	$9.81 - $15.4 $295,379 - $463,694	-30,110 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$12.09 - $14.68 $58,140 - $70,596	4,809 Added 19.01%	30,110 $407,000
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $28,818 - $32,907	2,175 Added 9.4%	25,301 $343,000
Q2 2021 Aug 09, 2021	BUY	$12.97 - $16.15 $42,930 - $53,456	3,310 Added 16.7%	23,126 $330,000
Q1 2021 May 10, 2021	BUY	$13.59 - $18.54 $269,299 - $367,388	19,816 New	19,816 $277,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.